Bing

SEARCH HISTORY

In 2007, Carl Icahn bought 5.2 million shares of Telik (OTCQB:TELK) stock. Icahn said he acquired the position believing the shares were undervalued. Icahn reportedly purchased the shares between $7 and $17 per share. By early 2009, Icahn sold his stake …
Seeking Alpha · 12/12/2012
NEW YORK (TheStreet) -- Telik (TELK) soared Tuesday after Monday's announcement that the oncology drug development company had entered into a definitive merger agreement with privately held MabVax Therapeutics. The two companies will combine …
The Street · 1/21/1985
Telik, Inc. (Nasdaq: TELK) and MabVax Therapeutics ... Under the terms of the merger agreement, MabVax will merge with a wholly-owned subsidiary of Telik in an all-stock transaction. The boards of directors of both companies have approved the merger ...
StreetInsider · 5/12/2014
More from Bing News
TELK shares were up nearly 26% at $1.57 each in late trading this afternoon, earlier climbing to within 9 cents of its 52-week high of $2.15 a share. Board members at both companies have signed off on the all-stock transaction, with MabVax shareholder also ...
NASDAQ · 5/13/2014
Today's Top NASDAQ Gainers include: Telik, Inc. (NASDAQ:TELK) moved up 22% at $1.25 on 462K shares. In the last one month the stock has become double on very unusual volume. Telik, Inc. (Telik) is a clinical-stage drug development company …
TransWorldNews · 6/5/2009
Shares of Telik, Inc. (TELK) were up over 30 percent today on news that the company ... Sometimes, a company needs to die for its stock to live. The merger announcement with MabVax Therapeutics was music to the ears of Telik shareholders.
Equities · 5/13/2014
MabVax merged with the wholly owned subsidiary of Palo Alto-based Telik (Nasdaq: TELK) in an all-stock transaction and in turn became a wholly owned subsidiary of Telik, according to the companies. The merger, initially announced May 12, became …
San Diego Business Journal · 7/10/2014
Resolve to keep your portfolio healthy: Help us pick the worst stock for 2008. I cringe as I anoint Pfizer ... The worst drugmaker distinction would go to Neurochem (Nasdaq: NRMX ) or Telik (Nasdaq: TELK ) -- both one-star CAPS stocks, by the way.
The Motley Fool · 1/14/2008
MabVax Therapeutics, Inc., a privately held cancer immunotherapy company and Telik, Inc. (Nasdaq: TELK), aclinical stage oncology drug ... MabVax will merge with a wholly-owned subsidiary of Telik in an all-stock transaction. The boards of directors ...
Benzinga · 5/13/2014
9, 2014 /PRNewswire/ -- MabVax Therapeutics Holdings, Inc. (TELK), a publicly-traded clinical stage cancer ... Stockholders also approved a reverse stock split at a ratio in the range of 1:5 to 1:15 and the authorization of additional common and preferred ...
Yahoo Finance · 9/9/2014